Dr. Daniel Raftery is an internationally renowned expert in metabolomics, with an emphasis on developing new diagnostics for breast, colon and esophageal cancers, plus new methods of analyzing metabolites in complex biological systems.
Metabolomics concentrates on developing a deep understanding of metabolism by identifying and characterizing many hundreds of small molecules or metabolites within biological systems. It is a relatively new field of study that the University of Washington has targeted as a strategic area of research with significant potential for better fundamental understanding of disease and health, as well as for the translation of new technologies to the clinic.
A WRF Faculty Recruitment Award of $500,000 has helped bring Dr. Raftery to UW, where he heads the Northwest Metabolomics Research Center and holds professorships in the Anesthesiology & Pain Medicine and Chemistry Departments. He is also a full member at the Fred Hutchinson Cancer Research Center and previously a professor of chemistry at Purdue University.
The grant will provide equipment and staff support for Dr. Raftery’s lab and will assist him in solidifying the program that will help ensure that UW is at the forefront of world-class metabolomics research.